MicroRNA-based therapy for glioblastoma: Opportunities and challenges.

Area of Science:

• Neuro-oncology
• Molecular Biology
• Biotechnology

Background:

• Glioblastoma (GBM) is an aggressive brain tumor with poor patient outcomes.
• Current treatments including surgery, radiation, and chemotherapy have limited efficacy.
• MicroRNAs (miRNAs) are key regulators of gene expression and implicated in GBM development and progression.

Purpose of the Study:

• To summarize recent advances in understanding GBM-related miRNAs.
• To highlight the potential of miRNAs as prognostic biomarkers and therapeutic targets for GBM.
• To review novel nanoparticle (NP)-based delivery systems for miRNA therapeutics.

Main Methods:

• Review of recent scientific literature (last 5 years) on GBM and miRNAs.
• Analysis of miRNA roles as oncomirs, tumor suppressors, and microenvironmental regulators.
• Examination of NP technologies for targeted miRNA delivery across the blood-brain barrier (BBB).

Main Results:

• Identification of specific GBM-associated miRNAs with prognostic and therapeutic potential.
• Demonstration of miRNA involvement in key GBM processes like proliferation, invasion, and resistance.
• Advancements in NP carriers for safe and effective in vivo miRNA delivery.

Conclusions:

• miRNAs represent promising targets and agents for novel GBM therapies.
• Nanoparticle-based delivery systems are crucial for overcoming challenges in miRNA therapeutics.
• Further research into miRNA biomarkers and targeted delivery is essential for improving GBM treatment.